ELVN

Enliven Therapeutics, Inc. · NASDAQ

Sector Health Technology
Industry Biotechnology
Website enliventherapeutics.com
Employees(FY) 44
ISIN US29337E1029

Performance

-2.3%

-14.17%

-2.6%

+9.77%

+62.36%

YTD

+84.33%

Profile

Enliven Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of small molecule inhibitors to help patients with cancer. The company's lead product candidates comprise ELVN-001, which is being evaluated in a Phase 1 clinical trial in adults with chronic myeloid leukemia; and ELVN-002, a Phase 1 clinical trial in adults with solid tumors with HER2 alterations. Enliven Therapeutics, Inc. is headquartered in Boulder, Colorado.

Advanced Technical Analysis

Technical Analysis of ELVN 2024-12-20

The stock indicators reflect a predominantly bearish sentiment, with the Moving Average Score at 3 and the Technical Score at 21, both indicating weak performance. The Oscillators Score at 40 suggests a neutral stance, but overall, the combined scores point to a lack of bullish momentum in the market.

Technical Scores and Rating

Moving Average Score

Oscillator Score

Technical Rating

Stock Analysis of ELVN

Stock Rank

Recent News & Updates

2024-12-13 07:59
BTIG Initiates Enliven Therapeutics at Buy With $42 Price Target(MT Newswires)
2024-11-13 16:05
Enliven Therapeutics Reports Third Quarter Financial Results and Provides a Business Update(PR Newswire)
2024-11-13 03:05
Enliven Therapeutics Reports Third Quarter Financial Results and Provides a Business Update(Prnewswire)
2024-11-07 16:05
Enliven Therapeutics to Present at the Jefferies London Healthcare Conference(PR Newswire)
2024-11-07 03:05
Enliven Therapeutics to Present at the Jefferies London Healthcare Conference(Prnewswire)
2024-10-31 08:50
JonesTrading Initiates Enliven Therapeutics at Buy With $36 Price Target(MT Newswires)
2024-10-18 16:38
Why this largely unknown company is one analyst's top biotech pick(Yahoo Finance Video)
2024-10-03 21:00
FDA Approves 16 New Cancer Treatments as Global Cancer Rates Skyrocket(Prnewswire)
2024-09-30 04:52
Enliven Therapeutics’ ELVN-001 shows promise in Phase I CML trial(Clinical Trials Arena)
2024-09-28 09:35
Enliven Therapeutics Announces Positive Data Update from Phase 1 Clinical Trial of ELVN-001 in Chronic Myeloid Leukemia(GlobeNewswire)
2024-09-27 21:35
Enliven Therapeutics Announces Positive Data Update from Phase 1 Clinical Trial of ELVN-001 in Chronic Myeloid Leukemia(Globenewswire)
2024-09-26 08:50
Here's Why Momentum in Enliven Therapeutics, Inc. (ELVN) Should Keep going(Zacks)
2024-09-18 16:05
Enliven Therapeutics Announces Details Regarding the Presentation of Updated ELVN-001 Phase 1a Data at the ESH-iCMLf 26th Annual John Goldman Conference on CML(GlobeNewswire)
2024-09-18 04:05
Enliven Therapeutics Announces Details Regarding the Presentation of Updated ELVN-001 Phase 1a Data at the ESH-iCMLf 26th Annual John Goldman Conference on CML(Globenewswire)
2024-09-09 14:05
Enliven Therapeutics' Leukemia Candidate Could Challenge Pfizer, AstraZeneca In Broader Target Market: Analyst(Benzinga)
2024-09-04 09:55
Wall Street Analysts See a 58.78% Upside in Enliven Therapeutics, Inc. (ELVN): Can the Stock Really Move This High?(Zacks)
2024-09-03 17:49
Enliven Therapeutics Insider Sold Shares Worth $269,841, According to a Recent SEC Filing(MT Newswires)
2024-08-24 09:08
Enliven Therapeutics (NASDAQ:ELVN) Is In A Good Position To Deliver On Growth Plans(Simply Wall St.)
2024-08-16 09:55
Wall Street Analysts Think Enliven Therapeutics, Inc. (ELVN) Could Surge 43.04%: Read This Before Placing a Bet(Zacks)
2024-08-13 16:05
Enliven Therapeutics Reports Second Quarter Financial Results and Provides a Business Update(GlobeNewswire)
2024-08-13 04:05
Enliven Therapeutics Reports Second Quarter Financial Results and Provides a Business Update(Globenewswire)
2024-07-16 17:44
Enliven Therapeutics Insider Sold Shares Worth $1,252,826, According to a Recent SEC Filing(MT Newswires)
2024-06-27 16:47
Enliven Therapeutics Insider Sold Shares Worth $259,902, According to a Recent SEC Filing(MT Newswires)
2024-05-29 16:05
Enliven Therapeutics to Present at Two Upcoming Investor Conferences(GlobeNewswire)
2024-05-29 04:05
Enliven Therapeutics to Present at Two Upcoming Investor Conferences(Globenewswire)
2024-05-20 17:06
Enliven Therapeutics Insider Sold Shares Worth $22,877,262, According to a Recent SEC Filing(MT Newswires)
2024-05-14 17:01
Enliven Therapeutics Q1 Loss Narrows(MT Newswires)
2024-05-14 16:05
Enliven Therapeutics Reports First Quarter Financial Results and Provides a Business Update(GlobeNewswire)
2024-05-14 10:54
ELVN Stock Earnings: Enliven Therapeutics Beats EPS for Q1 2024(Investorplace)
2024-05-14 04:05
Enliven Therapeutics Reports First Quarter Financial Results and Provides a Business Update(Globenewswire)

Page 1 of 2

previousnext

Disclaimer: The information provided here and on kavout.com site is for general informational purposes only. It does not constitute investment advice, financial advice, trading advice, or any other sort of advice. Kavout does not recommend that any investment decision be made based on this information. You are solely responsible for your own investment decisions. Please conduct your own research and consult with qualified financial advisors before making any investment. Kavout and its partners are participants in a number of affiliate advertising programs. As an Amazon Associate, Kavout or its partners earn from qualifying purchases from affiliate links. We also participate in other affiliate and advertising programs that provide a means for us to earn advertising fees by advertising and linking to third-party websites.